CorVel Corp

CorVel Corp (CRVL) Stock Analysis

$69.740

+0.872 (+1.25%)At close

Loading chart…
High
70.370
Open
69.700
VWAP
69.70
Vol
191.00K
Mkt Cap
4.32B
Low
68.988
Amount
13.31M
EV/EBITDA, TTM
0.00

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

AI analysis of CorVel Corp (CRVL)

buy

CorVel Corp is a good buy right now, primarily driven by a current price of 69.24 and a forward P/E ratio of 23.75, indicating growth potential. The recent appointment of a new CEO and a significant Q1 profit growth to $32.22 million, with EPS rising to $0.63, further supports this positive outlook. However, a risk to consider is the 1-year change of -20.98%, which reflects past volatility.

Valuation Metrics

The current forward P/E ratio for CorVel Corp (CRVL) is 23.75, compared to its 5-year average forward P/E of 92.66.

Forward P/E

Undervalued
5Y Average P/E
92.66
Current P/E
23.75
Overvalued
130.79
Undervalued
54.53

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
6.97
Current P/S
0.00
Overvalued
8.88
Undervalued
5.06

Whales holding CRVL

K

Kayne Anderson Rudnick Investment Management, LLC

+ HoldingCRVL

+3.49%

3M Return

Events Timeline

2026-06-01 (ET)

16:40:00

CorVel Appoints Sarah Scott as CEO

2026-05-20 (ET)

06:20:00

Q4 Revenue Reaches $248.54M

2026-02-03 (ET)

06:20:00

Q3 Revenue Reaches $236M vs. $228M Last Year

2025-02-13 (ET)

06:36:59

CorVel appoints Scott as Executive Vice President of Product

2024-12-24 (ET)

12:16:10

CorVel announces effectiveness of three-for-one forward stock split

News

CRVL FAQ — answered by Alphio AI

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner. It operates in the Healthcare sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

CorVel Corp is a good buy right now, primarily driven by a current price of 69.24 and a forward P/E ratio of 23.75, indicating growth potential. The recent appointment of a new CEO and a significant Q1 profit growth to $32.22 million, with EPS rising to $0.63, further supports this positive outlook. However, a risk to consider is the 1-year change of -20.98%, which reflects past volatility.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started